Cervical Cancer Treatment

Cervical cancer is a malignant tumor originating from squamous or glandular epithelium of the cervix, mainly seen in women aged 30 to 55. With the spread of vaccination and screening, early detection rates have increased, but many patients are still diagnosed at middle or late stages. Treatment includes surgery, radiotherapy, chemotherapy, and the emerging immune reconstruction cell therapy. Without timely intervention, the disease may rapidly worsen, affecting the reproductive, urinary, and digestive systems, and may even be life-threatening.

Emerging Treatments

Immune Reconstruction Cell Therapy

Immune reconstruction cell therapy is a novel approach that activates the patient’s own immune system to recognize and eliminate tumor cells. It is particularly suitable for middle-to-late-stage or recurrent cervical cancer. By reinfusing autologous immune cells expanded in vitro, this therapy enhances anti-cancer immunity, reduces recurrence and metastasis risks, and improves quality of life.

Its main advantages in cervical cancer treatment include:

① Improve immune suppression and rebuild an anti-cancer immune environment

② Can be combined with chemotherapy and radiotherapy to enhance overall efficacy

③ Effectively control tumor progression and prolong disease-free survival

④ Mild side effects, suitable for elderly, frail, and recurrent patients

⑤ Personalized treatment plans tailored to different disease stages

In clinical practice, cervical cancer patients undergoing surgery, radiotherapy, or chemotherapy often face immune dysfunction, higher infection risk, and slow recovery. To better support patients, improve tolerance, and enhance quality of survival, immune reconstruction plans should be scientifically staged according to different treatment cycles.

● Short-term Plan: Quickly boost immunity through immune cell reinfusion, enhancing the effects of anti-cancer treatment.

● Mid-term Plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standard regimens.

● Long-term Plan: Strengthen overall immunity through immune cell, intestinal, elemental, and nutritional reconstruction, improving quality of life and extending survival.

Conventional Treatments

1. Surgery

For early cervical cancer, radical hysterectomy remains one of the main treatments. The surgical scope includes the cervix, uterus, part of the vagina, and surrounding lymphatic tissue. Some younger patients wishing to preserve fertility may undergo conization or fertility-preserving surgery, but strict lesion assessment is required. Recovery is relatively fast, and surgery can remove lesions in one procedure.

2. Radiotherapy

Radiotherapy is the mainstay for middle-to-late-stage cervical cancer. It includes external beam radiation and brachytherapy. Radiotherapy destroys cancer cell DNA, preventing replication and spread, and is suitable for inoperable cases or as adjuvant therapy. Modern image-guided techniques have improved precision while reducing damage to surrounding tissues such as the bladder and rectum.

3. Chemotherapy

Chemotherapy is mainly used for advanced cases, postoperative adjuvant therapy, or concurrent chemoradiotherapy. Cisplatin-based regimens enhance radiosensitivity or control distant metastases. In recent years, drugs like paclitaxel and gemcitabine have been increasingly used in multi-drug regimens to improve efficacy. Chemotherapy has significant side effects and requires supportive measures to protect nutrition, liver, and kidney function.

4. Targeted Therapy and Supportive Treatments

In recent years, drugs targeting angiogenic factors, such as bevacizumab, have been introduced into treatment protocols, providing new hope for some advanced patients. In addition, Traditional Chinese Medicine (TCM), psychological counseling, and nutritional support play important roles in overall care, helping improve patient quality of life.

Conclusion

Cervical cancer treatment should be individualized based on stage, pathology, and patient condition. Experts from United Life International Medical Center emphasize that immune reconstruction cell therapy provides a new direction for cervical cancer management. Combining it with multiple treatment modalities can improve efficacy, prolong survival, and reduce recurrence risks, making it an approach worthy of attention and promotion.